|
|
||||||||
Department of Physiology, Northwestern University Medical School, Chicago, Illinois 60611
| |
ABSTRACT |
|---|
|
|
|---|
Brain stimulation or activation of certain reflexes can result in differential activation of the two populations of adrenal medullary chromaffin cells: those secreting either epinephrine or norepinephrine, suggesting that they are controlled by different central sympathetic networks. In urethan-chloralose-anesthetized rats, we found that antidromically identified adrenal sympathetic preganglionic neurons (SPNs) were excited by stimulation of the rostral ventrolateral medulla (RVLM) with either a short (mean: 29 ms) or a long (mean: 129 ms) latency. The latter group of adrenal SPNs were remarkably insensitive to baroreceptor reflex activation but strongly activated by the glucopenic agent 2-deoxyglucose (2-DG), indicating their role in regulation of adrenal epinephrine release. In contrast, adrenal SPNs activated by RVLM stimulation at a short latency were completely inhibited by increases in arterial pressure or stimulation of the aortic depressor nerve, were unaffected by 2-DG administration, and are presumed to govern the discharge of adrenal norepinephrine-secreting chromaffin cells. These findings of a functionally distinct preganglionic innervation of epinephrine- and norepinephrine-releasing adrenal chromaffin cells provide a foundation for identifying the different sympathetic networks underlying the differential regulation of epinephrine and norepinephrine secretion from the adrenal medulla in response to physiological challenges and experimental stimuli.
adrenal medulla; sympathetic nerve activity; hypoglycemia; rostral ventrolateral medulla; 2-deoxyglucose; vasoconstrictor neurons; intermediolateral nucleus; blood pressure; splanchnic nerve activity
| |
INTRODUCTION |
|---|
|
|
|---|
ANATOMIC STUDIES have provided histochemical differentiation of the populations of adrenal medullary chromaffin cells secreting epinephrine and those secreting norepinephrine (13, 15, 23, 25). Several lines of evidence have suggested that the two populations of adrenal chromaffin cells are regulated by distinct neural pathways to the adrenal medulla. First, nerve terminals on epinephrine-secreting chromaffin cells are morphologically different from those on norepinephrine-secreting cells (24). More direct evidence for the existence of distinct populations of sympathetic preganglionic neurons (SPNs) innervating cat epinephrine- and norepinephrine-synthesizing chromaffin cells comes from an elegant anatomic study showing that adrenal SPNs that contain the calcium-binding protein calretinin terminate in the vicinity of noradrenergic chromaffin cells and are located more caudally than adrenal SPNs, which do not contain calretinin and whose terminals are located preferentially among adrenergic chromaffin cells (18). Whether this is also the case in the rat remains to be determined. Second, stimulation at different hypothalamic sites in the cat (21, 42) or stimulation of the splanchnic nerve at different frequencies (17, 29) can evoke selective or differential secretion of adrenal epinephrine or norepinephrine, suggesting that medullary chromaffin cells secreting epinephrine and those that secrete norepinephrine are controlled by different descending and preganglionic pathways. Similar data are available in the rat. Third, certain stimuli in the rat, such as the hypoglycemia induced by insulin or mimicked by 2-deoxyglucose (2-DG), produce a response consistent with a selective activation of epinephrine-secreting adrenal chromaffin cells (22, 34, 43, 48, 53, 54), while, in contrast, acute cold exposure in the rat results in a preferential secretion of norepinephrine (54).
In the present study, we sought to provide electrophysiological evidence for the independent regulation of adrenergic and noradrenergic chromaffin cells by characterizing the physiological and stimulus-evoked responses of adrenal SPNs. Because the chromaffin cells of the adrenal medulla are the sole sympathetic target tissue directly innervated by SPNs, the adrenal medulla provides a unique opportunity to study antidromically identified SPNs controlling a known target tissue. We reasoned that adrenal SPNs regulating adrenergic chromaffin cells could be differentiated from those regulating noradrenergic chromaffin cells by their excitatory responses to the glucopenia after 2-DG, which produces a selective increase in adrenal epinephrine secretion (31, 34, 48). In addition, we determined the responses of adrenal SPNs to stimulation in the rostral ventrolateral medulla (RVLM), a location of adrenal sympathetic premotor neurons (47, 57), and to acute activation of the baroreceptor reflex, a potent, short-term regulator of cardiac and vasoconstrictor sympathetic outflows that has also been shown to modulate adrenal nerve activity in the rat (26, 51). Our results provide strong support for the existence of a unique population of adrenal SPNs controlling the secretion of epinephrine and suggest that the adrenal SPNs regulating noradrenergic chromaffin cells behave in a manner similar to that expected of SPNs controlling vasoconstriction.
| |
METHODS |
|---|
|
|
|---|
General procedures.
Male Sprague-Dawley rats (300-400 g) were anesthetized with
intravenous injections of urethane (800 mg/kg) and
-chloralose (70 mg/kg). The trachea, femoral vein, and femoral artery were cannulated
for artificial ventilation, drug administration, and measurement of
arterial pressure, respectively. Rectal temperature was maintained at
37°C with a thermostatically controlled heating lamp and table.
Animals were placed in a stereotaxic apparatus and spinal investigation
unit with the incisor bar at
12 mm below the interaural line and the
spinal clamp on the T10 and T11 vertebrae. An
occipital craniotomy and T7-T9 laminectomy were
performed, and exposed nervous tissue was covered with a warmed mixture
of mineral oil and silicone grease. After paralysis with
d-tubocurarine (0.8 mg/kg iv), animals were respired with
100% oxygen at a minute volume of 140-180 ml. Respiratory rate or
tidal volume was adjusted to maintain expired CO2 between
3.5 and 4.5%. A bilateral pneumothorax reduced respiratory
pump-related movements of tissue near the recording electrode. After
4 h, supplemental doses of
-chloralose (20 mg/kg iv) were given
every 2 h.
Recording and identification of adrenal SPNs. The extracellular action potentials of adrenal SPNs were recorded (capacity coupled, 300-3,000 Hz) with glass microelectrodes containing a carbon filament. The indifferent electrode was inserted in muscle adjacent to the vertebral column. The region between 700 and 1,100 µm ventral to the dorsal surface of the spinal cord and along the dorsal root entry zone was explored for adrenal SPNs that were antidromically identified with stimuli (20-200 µA, 1 ms, 0.5 Hz) applied to the left adrenal nerve just proximal to its entrance to the adrenal capsule. Three criteria were used to establish the antidromic nature (35, 37) of the responses of spinal neurons to adrenal nerve stimulation: 1) constant onset latency, 2) high following frequency, and 3) collision with spontaneous action potentials or those evoked orthodromically by stimulation in the RVLM. To perform time-controlled collision tests, individual unit action potentials were selected from ongoing activity and used to trigger an adrenal nerve stimulus at a specified delay. At the end of some experiments, current (15 µA, 1 min) was passed through the carbon filament to make a small lesion marking the SPN recording site. These were consistently located within the principal nucleus of the intermediolateral (IML) cell column.
RVLM stimulation. A tungsten microelectrode with a 50-µm exposed tip was used to deliver paired (6-ms interpulse interval) stimuli (50-300 µA, 1 ms, 0.5 Hz) to the region of the RVLM containing spinally projecting, sympathetic premotor neurons, including those projecting monosynaptically to adrenal SPNs (47, 57). The stimulating electrode was positioned 2.6 mm rostral, 1.9 mm lateral, and 2.4 mm ventral to the calamus scriptorius. In some experiments, the stimulating microelectrode was replaced with a micropipette (20-µm tip diameter) containing the excitatory amino acid L-glutamate (10 mM), from which microinjections (60 nl) were made to determine the effect on adrenal SPN discharge of exciting only neurons in RVLM. At the conclusion of the experiment, the position of the stimulating electrode and/or microinjection pipette was marked with an electrophoretic deposit of fast green dye from a micropipette stereotaxically positioned at the same RVLM site. After perfusion with fixative, the brain stem was sliced (50 µm), and the locations of dye marks were plotted on drawings from a rat atlas (39).
Activation of the baroreceptor reflex. To determine the effect of activation of baroreceptor afferent nerves on the discharge of adrenal SPNs, the left aortic depressor nerve (ADN) was dissected in the neck and separated from the cervical vagus nerve, and the sectioned central end was placed on platinum hook electrodes for stimulation with square wave pulses. The following two stimulus paradigms were used: 1) a short burst of three pulses, 6-ms interpulse interval, 20-100 µA, 1 ms duration, 0.25 Hz and 2) high-frequency train of 20 Hz for 3 s, 1 ms duration, 20-100 µA. Natural stimulation of the baroreceptors was produced by the rise in arterial pressure after an intravenous bolus injection of phenylephrine (0.1 ml, 50-100 µg/ml).
Adrenal SPN response to glucopenia. To determine the response of adrenal SPNs to simulated hypoglycemia [a stimulus that produces selective release of adrenal epinephrine (22, 43, 53, 54)], spontaneous SPN activity was recorded before and for at least 15 min after an intravenous bolus of 2-DG (250 mg/kg). Histograms (1-s bins) of unit activity were computed, and differences between control activity levels and those at various intervals after the 2-DG administration were determined.
Data analysis. Action potentials of adrenal SPNs and the arterial pressure were digitized at 22 kHz and recorded on VCR tape along with 5-volt pulses coincident with stimuli applied to the adrenal or aortic nerves or to the RVLM. Computer-aided data analysis consisted of stimulus- or arterial pulse-triggered histograms of the discharges of adrenal SPNs. To identify poststimulus periods of increased or decreased probability of discharge of adrenal SPNs, the mean discharge rate during the 100-ms period before stimulus delivery was determined from peristimulus time histograms of adrenal SPN discharge. The onsets of excitatory or inhibitory responses of adrenal SPNs were identified as the first bin in peristimulus time histograms that was followed by at least three bins whose values were greater than (or less than, for inhibitory responses) the mean control discharge rate and whose values continued to increase (or decrease, for inhibitory responses). The results are expressed as means ± SE. Significant differences between groups were determined with the Student's t-test.
| |
RESULTS |
|---|
|
|
|---|
Antidromic identification of adrenal SPNs.
In 81 rats, 139 neurons in the IML region of thoracic segments
T8-T10 (located beneath thoracic vertebrae
T7-T9) responded to stimulation of the adrenal
nerve at a constant latency and followed paired adrenal nerve stimuli
separated by <5 ms. The antidromic nature of the constant
latency responses of these neurons was confirmed with the collision
test. In the example in Fig. 1, adrenal
SPN action potentials were evoked at a constant onset latency (51 ms)
when adrenal nerve stimuli were delivered at 53.5 ms after a
spontaneous discharge of the SPN (Fig. 1, trace 1) but
collided when adrenal nerve stimuli were applied at 52 ms after a
spontaneous SPN action potential (Fig. 1, trace 2). As previously described (35, 37), the SPN axonal refractory
period was determined by delivering twin pulses to the adrenal nerve at
an interval (40 ms; Fig. 1, traces 3 and 4) after
a spontaneous action potential, resulting in collision of the first
antidromic spike. The SPN recording showed that a second antidromically
evoked action potential was generated when the interpulse interval was 2.4 ms (Fig. 1, trace 3), i.e., equal to or greater than the
axonal refractory period, but not when the interpulse interval was 2.2 ms (Fig. 1, trace 4).
|
RVLM-evoked discharge of adrenal SPNs. All of the adrenal SPNs were excited by paired stimuli applied to the region of the RVLM containing sympathetic premotor neurons. Most of the SPNs responded to each RVLM stimulus with a single action potential. Threshold responses in which only 10-20% of the RVLM stimuli evoked an SPN spike typically occurred at stimulus currents between 40 and 80 µA. Maximal responses in which an SPN action potential occurred for nearly every RVLM stimulus were attained at a mean current of 225 µA. Splanchnic SPNs, which would include those with axons in the adrenal nerve, were previously divided into four groups on the basis of the patterns and latencies of their responses to RVLM stimulation (37). The antidromically identified adrenal SPNs in the present study exhibited RVLM stimulus-evoked responses characteristic of the splanchnic SPNs in either group I (short onset latency excitation) or group IV (early inhibition and late excitation). The adrenal SPNs with the characteristics of splanchnic group IV SPNs were designated Epi Adr SPNs, and adrenal SPNs with RVLM stimulus-evoked responses similar to those of splanchnic group I SPNs were designated NE Adr SPNs.
Epi Adr SPN responses to RVLM stimulation.
In 71 (51%) adrenal SPNs, RVLM stimulation produced a biphasic
response (Fig. 2A) consisting
of an early reduction in unit action potential probability followed by
a period of increased discharge probability during which the unit could
fire more than one time to a paired RVLM stimulus. This response,
characteristic of Epi Adr SPNs, is shown in the peristimulus time
histogram in Fig. 2A, top. The probability of
unit discharge fell below control levels for ~80 ms after the RVLM
stimulation (mean control discharge rate in the 100 ms before the
stimulation: 4.9 Hz; mean discharge rate between 15 and 80 ms after the
stimulation: 1.8 Hz). This was followed by a period of increased
discharge probability lasting from 110 to 180 ms after the RVLM
stimulus, during which the 100 RVLM stimuli evoked 86 spikes with a
mean latency of 139 ms and a modal latency of 150 ms. These two phases
of the RVLM stimulus-evoked response of Epi Adr SPNs are clearly seen
in the mean peristimulus time histogram (Fig. 2A,
bottom) derived from the individual response histograms of
71 Epi Adr SPNs. The early period of inhibition lasted for 68 ms after
the stimulus, and during this time (i.e., from the end of the stimulus
blanking at 12-68 ms) the mean discharge rate averaged 64% of
control. The late period of excitation of Epi Adr SPNs lasted for 108 ms, between 76 and 184 ms, during which the mean response latency was
129 ± 2.8 ms and the modal response latency was 136 ms.
|
|
NE Adr SPN responses to RVLM stimulation. Sixty-eight (49%) adrenal SPNs responded to RVLM stimulation with single action potentials that all had latencies <50 ms. The peristimulus time histogram for a representative NE Adr SPN (Fig. 2C, top) indicates a dramatic, short-lasting increase in discharge probability between 20 and 40 ms after the RVLM stimuli (mean response latency: 28.8 ms). This excitation was usually followed by a period of decreased discharge or silence often lasting for 100-200 ms. The mean peristimulus time histogram derived from the responses of 68 NE Adr SPNs (Fig. 2C, bottom) shows the consistency of this early and remarkable excitation, which occurred from 12 ms (the end of the stimulus-blanking period) to 52 ms, with a mean response latency of 29 ± 0.9 ms (range: 16-47 ms). As shown in Fig. 3, bottom, the antidromic latencies of NE Adr SPNs ranged from 7 to 70 ms (mean: 37 ± 2.0 ms), corresponding to approximate conduction velocities between 0.47 and 4.7 m/s. These did not differ from those for Epi Adr SPNs.
NE Adr SPNs were also excited by activation of RVLM neurons with microinjections of glutamate. In the example in Fig. 2D, the discharge of an adrenal SPN with an RVLM stimulus-evoked response pattern characteristic of NE Adr SPNs (see Fig. 2C) was increased from a basal rate of 2 spikes/s to a peak rate of 10 spikes/s after an ipsilateral microinjection of glutamate (10 mM, 60 nl) in the RVLM, which also resulted in an increase in mean arterial pressure of 51 mmHg. Similar stimulation of neuronal cell bodies in the RVLM produced an increase in discharge rate of 171 ± 14.8% in four NE Adr SPNs and an increase in mean arterial pressure of 54 ± 2.2 mmHg.Baroreceptor reflex influences on the discharge of Adr SPNs.
Adrenal SPNs with RVLM stimulus-evoked responses characteristic of Epi
Adr SPNs (see Fig. 2A) had a mean spontaneous discharge frequency of 5.6 ± 0.3 Hz at a mean arterial pressure of 99 ± 3.0 mmHg. Perisystolic averaging indicated that the spontaneous discharge of Epi Adr SPNs was not synchronized to the cardiac cycle,
suggesting that the activity of these neurons was not strongly influenced by the baroreceptor reflex. In the example in Fig. 4A, there is no significant
alteration in the average spikes per bin for an Epi Adr SPN over the
course of 1.5 cardiac cycles, including two systolic pressure increases
of ~70 mmHg. The average perisystolic time interval histogram (Fig.
4B) for 15 Epi Adr SPNs indicates that, although there was a
tendency for a reduced discharge probability during middiastole, this
modulation represented an inhibition of only 18% of the normalized
maximum firing rate over the course of the cardiac cycle (average mean
arterial pressure: 108 mmHg).
|
|
Responses of Adr SPNs to 2-DG-induced glucopenia. Because plasma levels and adrenal secretion rates of epinephrine and norepinephrine have been shown to be differentially sensitive to reductions in blood glucose (53, 54), we reasoned that adrenal SPNs regulating the discharge of epinephrine-secreting chromaffin cells should be excited during the glucopenia produced by 2-DG, while little or no change in discharge frequency would be expected of adrenal SPNs regulating the activity of chromaffin cells secreting norepinephrine.
We tested the response of 20 adrenal SPNs with RVLM stimulus-evoked responses characteristic of Epi Adr SPNs (see Fig. 2A) and 17 adrenal SPNs with RVLM stimulus-evoked responses characteristic of NE Adr SPNs (see Fig. 2C) to an intravenous bolus of 2-DG (250 mg/kg). In the example shown in Fig. 6A, the discharge rate of an Epi Adr SPN increased from 5.2 spikes/s during the control preinjection and early postinjection period (inset on left) to 8.6 spikes/s during the sustained activation (inset on right) after the 2-DG injection. The mean post-2-DG time interval histogram for Epi Adr SPNs (Fig. 6B) shows that 2-DG produced a significant (P < 0.05) increase in discharge frequency beginning ~30 s after the 2-DG injection. This excitation reached a plateau (mean discharge frequency: 143 ± 0.7% of control) between 1 and 2 min after the 2-DG injection and remained at this level for at least 5 min (mean discharge frequency: 144 ± 12.4% of control at 180 s; 149 ± 10.3% of control at 240 s; 148 ± 14.9% of control at 300 s).
|
Location of stimulation and microinjection sites in the RVLM.
Figure 7, top, shows two
histological sections at the level of the RVLM containing fast green
dye spots indicating the positions of the stimulating electrode in two
experiments in which Epi and NE Adr SPNs were recorded. These
stimulation sites were located ventral to the compact division of the
nucleus ambiguus, close to the ventral surface of the medulla and
within 500 µm of the caudal end of the facial nucleus. Figure 7,
bottom, shows the stimulation sites in the RVLM on a drawing
(39) through the rat medulla 2.5 mm rostral to the calamus
scriptorius. Each of the recovered sites is within the vasomotor region
of the RVLM, which contains sympathetic premotor neurons regulating
vasoconstrictor sympathetic outflow (36) and adrenal
medullary catecholamine secretion (47, 57).
|
| |
DISCUSSION |
|---|
|
|
|---|
The principal new finding from these experiments is that adrenal SPNs can be divided into two distinct populations based of their evoked and reflex responses. Epi Adr SPNs were markedly excited during the glucopenia evoked by intravenous 2-DG administration, consistent with SPNs that regulate the secretion from adrenal, epinephrine-producing chromaffin cells, whereas NE Adr SPNs were unaffected by 2-DG, consistent with SPNs regulating the discharge of adrenal, norepinephrine-secreting chromaffin cells. Epi Adr SPNs consistently responded to electrical stimulation of the RVLM with a biphasic change in discharge probability: an early inhibition followed by a long latency excitation. In contrast, the response of NE Adr SPNs to RVLM stimulation was always a dramatic, short latency excitation. Epi Adr SPNs exhibited little or no sensitivity to the baroreceptor reflex, as indicated by the relative absence of a cardiac cycle-related modulation of their spontaneous discharge and only a minimal inhibition of their discharge during large, phenylephrine-evoked pressor responses or in response to stimulation of baroreceptor afferents in the ADN. The discharge of NE Adr SPNs, by comparison, was exquisitely sensitive to baroreceptor reflex activation: the perisystolic time histograms of NE Adr SPNs contained bins with zero counts, and natural (increased arterial pressure) or electrical activation of the baroreceptor reflex produced a prompt and complete inhibition of NE Adr SPN discharge. These data provide the first functional differentiation among populations of SPNs, thereby supporting the existence of functional specificity at the level of the SPN (1, 18, 40). These results also form a foundation for determining the organization and properties of the networks selectively controlling adrenal epinephrine secretion (21, 52, 54), and they suggest that the central pathways determining adrenal norepinephrine release may be indistinguishable from those controlling sympathetic tone to vasoconstrictor targets.
Several lines of evidence indicate that the SPNs from which we recorded innervated the epinephrine- and the norepinephrine-secreting adrenal chromaffin cells. The SPNs reported in this study were found in thoracic segments T8-T10, which are within the T5-T11 distribution containing the majority of adrenal SPNs retrogradely labeled after adrenal medullary injection of tracer in the rat (2, 28, 44, 46, 47) and other species (18, 27). Jensen et al. (27) have shown that the population of SPNs innervating the rabbit adrenal medulla is separate from that innervating ganglion cells in the aorticorenal ganglion, indicating that the axons of adrenal SPNs project selectively to the adrenal medulla. It seems unlikely that our antidromic stimulus would have activated SPN axons other than those of adrenal SPNs, since the adrenal nerve was always well isolated and the stimulating electrode hooks were positioned close to the entrance of the adrenal nerve in the adrenal capsule. Although adrenal SPNs may innervate adrenal medullary ganglion cells and adrenal chromaffin cells (14), the former appear to be a minor cell population in the adrenal medulla, and it is not known whether or when they receive a unique preganglionic input. In view of the conclusion, based on anatomic data, that there are ~2.7 times as many epinephrine-containing as norepinephrine-secreting chromaffin cells in the adult rat medulla (50), we were initially surprised to record from nearly equal numbers of Epi Adr SPNs and NE Adr SPNs. However, given the potential for different degrees of convergence of adrenal SPN inputs onto chromaffin cells (24) and our small sample size in each rat, we might not expect a close correlation between the relative numbers of each type of adrenal SPN and chromaffin cells.
The simulated hypoglycemia induced by the glucopenic agent 2-DG produces a strong stimulus for the release of adrenal epinephrine, with a relatively minor increase in plasma norepinephrine, an indeterminate fraction of which arose as "spillover" from sympathetic postganglionic terminals (7). This result parallels that seen with insulin-induced hypoglycemia (11, 16, 53) and with chronic 2-DG administration (41). Because only one of the populations of adrenal SPNs was excited by 2-DG, we conclude that 2-DG administration was an effective stimulus for distinguishing adrenal SPNs projecting to epinephrine-secreting chromaffin cells from those regulating adrenal norepinephrine release. Our results extend those indicating a large increase in preganglionic adrenal nerve activity after 2-DG administration (7) to suggest that this increase was comprised predominantly of the activation of adrenal SPNs innervating epinephrine-secreting chromaffin cells.
Both electrical and chemical stimulation of the population of sympathetic premotor neurons in the RVLM activated Epi Adr SPNs and NE Adr SPNs, consistent with the anatomic finding that the RVLM contains adrenal sympathetic premotor neurons (47, 56, 57). Although the characteristics of the excitatory responses of Epi Adr SPNs and NE Adr SPNs to chemical excitation of RVLM neurons were not markedly different, there were significant differences in the latencies of the action potentials evoked in Epi Adr SPNs and in NE Adr SPNs after electrical stimulation of RVLM. The mean response latency of NE Adr SPNs (29 ms, Fig. 2C) to RVLM stimulation corresponds to an average conduction velocity of ~2.4 m/s, which falls within the range of "rapidly conducting" RVLM spinal, sympathetic premotor neurons with strong baroreceptor reflex sensitivity (6, 32, 36, 45). In combination with the high degree of baroreceptor reflex sensitivity of NE Adr SPNs, these results suggest that NE Adr SPNs receive baroreceptor-modulated, premotor excitatory inputs from RVLM neurons similar to those that provide the tonic excitation to vasoconstrictor SPNs.
In contrast, RVLM stimulation excited Epi Adr SPNs with a mean latency to peak of 129 ms (Fig. 2A), indicating an average conduction velocity of RVLM premotor neurons to Epi Adr SPNs of ~0.5 m/s, which is within the range of "slowly conducting" sympathetic premotor neurons (6, 36, 45). This observation raises several points. The absence of baroreceptor modulation of the discharge of Epi Adr SPNs suggests that their excitatory premotor inputs from RVLM would arise from an as-yet-undescribed population of RVLM neurons with slowly conducting spinal axons, but without the strong inhibitory responses to increases in arterial pressure that constitute a hallmark of sympathetic premotor neurons. The recent finding that all slowly conducting sympathetic premotor neurons (albeit barosensitive) in the RVLM are C1 cells (45) leads to the interesting speculation that a subpopulation of the phenylethanolamine-N-methyltransferase-containing neurons in RVLM without baroreceptor sensitivity may provide a premotor input to Epi Adr SPNs. Although most studies of sympathetic premotor neurons in the RVLM focus on those that are strongly inhibited by baroreceptor input, slowly conducting, RVLM spinal neurons without baroreceptor sensitivity have been described (5). It is also possible that the RVLM stimulus-evoked excitation of Epi Adr SPNs is not direct, but rather it may involve a synaptic relay in which a rapidly conducting RVLM neuron activates a more slowly conducting, medullary or spinal input to Epi Adr SPNs. In this regard, adrenal SPNs receive a direct input, which may be serotonergic (2), from medullary raphe nuclei (3, 47, 56) that contain neurons with slowly conducting axons and that receive inputs from the RVLM. Finally, considering the short latency inhibition of Epi Adr SPNs seen with electrical stimulation in RVLM, it is worth noting that the period of the RVLM stimulus-evoked inhibition of Epi Adr SPNs overlaps that of the simultaneously evoked excitation of NE Adr SPNs, indicating that this inhibitory input is selective for Epi Adr SPNs, leading to the speculation that the descending inputs to NE Adr SPNs may activate a spinal inhibitory interneuronal input to Epi Adr SPNs. Although this inhibition of Epi Adr SPNs may have been mediated by activation of local axons within RVLM, since it was not seen with glutamate stimulation of the RVLM, the latter also activated an excitatory input to Epi Adr SPNs that may have masked an inhibition.
Our conclusion that the discharge of Epi Adr SPNs is not significantly
influenced by the baroreceptor reflex is derived from their
consistently weak responses using the following three different approaches to activation of the baroreceptor reflex: modulation of the
SPNs' spontaneous discharge probability relative to the occurrence of
the systolic pressure rise, baroreceptor loading during the pressor
response to
-adrenergic receptor stimulation, and electrical
stimulation of the baroreceptor afferents in the ADN. The effectiveness
of each of these was indicated by the dramatic reductions in discharge
frequency of NE Adr SPNs to the same stimulus, often within the same
experiment. In combination with the responses of Epi Adr SPNs to 2-DG
administration, this result suggests that sympathetically regulated
secretion of adrenal epinephrine is determined more by signals
pertaining to metabolic homeostasis (such as plasma glucose levels)
than by those involved in the short-term regulation of arterial
pressure (19), although this has not been explicitly
tested in rats. Just the opposite appears to be true for the
supraspinal sympathetic pathways controlling the activity of NE Adr
SPNs, whose discharge could easily be completely inhibited by
baroreceptor activation but was little affected by the 2-DG stimulus.
Several reports have demonstrated some baroreceptor reflex regulation of adrenal nerve activity in the rat (8, 10, 26, 30, 38, 49). However, when ganglionic blockade was used to differentiate adrenal nerves that contained predominantly preganglionic vs. postganglionic axons, the former were found to have no cardiac rhythmicity, whereas 50% of the latter had a weak cardiac rhythmicity (9). Curiously, the same group indicated subsequently (8) that preganglionic adrenal nerve activity was decreased (although not as much as renal or postganglionic adrenal nerve activity) during a phenylephrine-evoked increase in arterial pressure. Because the adrenal nerves contain not only the axons of SPNs innervating epinephrine-synthesizing chromaffin cells but also the preganglionic axons of SPNs innervating the norepinephrine-synthesizing chromaffin cells and postganglionic axons innervating cortical cells and arteriolar smooth muscle, it is not possible to determine from these data whether such responses are indicative of baroreceptor control of the discharge of SPNs specifically controlling adrenal epinephrine secretion. Although determinations of catecholamine levels in adrenal venous blood could provide more specific information on the baroreflex regulation of the secretion of the two adrenal catecholamines, the sensitivity of the adrenal chromaffin cells to blood-borne agents, including ANG II (4, 12, 20, 33, 55), could produce significant changes in catecholamine secretion (e.g., during severe hypotension) independent of changes in neural input to chromaffin cells. In this regard, the responses of Epi Adr SPNs to hypotensive stimuli were not tested in this study. Finally, the differences between our results and those indicating a reduction in epinephrine in adrenal venous blood during a phenylephrine-evoked pressor response (26) may have arisen from a marked reduction in adrenal blood flow (not reported) leading to a compromised recovery of epinephrine during the pressor response.
In summary, these results provide a characterization of adrenal SPNs that has allowed us to distinguish those regulating adrenal chromaffin cells secreting epinephrine from those controlling adrenal norepinephrine release. The dramatic differences between these two populations of adrenal SPNs in their reflex- and centrally evoked responses suggest that their discharge is controlled by different central neural circuits, including unique populations of adrenal sympathetic premotor neurons in the RVLM. Our findings support the distinct functional organization of the networks governing the activity of Epi Adr SPNs and NE Adr SPNs that has been proposed (18, 52) to account for the differential regulation of epinephrine and norepinephrine secretion from the adrenal medulla in response to physiological challenges and experimental stimuli.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: S. F. Morrison, Dept. of Physiology (M211), Northwestern Univ. Medical School, 303 E. Chicago Ave., Chicago, IL 60611 (E-mail: s-morrison2{at}northwestern.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 24 April 2000; accepted in final form 10 July 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Appel, NM,
and
Elde RP.
The intermediolateral cell column of the thoracic spinal cord is comprised of target-specific subnuclei: evidence from retrograde transport studies and immunohistochemistry.
J Neurosci
8:
1767-1775,
1988[Abstract].
2.
Bacon, SJ,
and
Smith AD.
Preganglionic sympathetic neurones innervating the rat adrenal medulla: immunocytochemical evidence of synaptic input from nerve terminals containing substance P, GABA or 5-hydroxytryptamine.
J Auton Nerv Syst
24:
97-122,
1988[ISI][Medline].
3.
Bacon, SJ,
Zagon A,
and
Smith AD.
Electron microscopic evidence of a monosynaptic pathway between cells in the caudal raphe nuclei and sympathetic preganglionic neurons in the rat spinal cord.
Exp Brain Res
79:
589-602,
1990[ISI][Medline].
4.
Breidert, M,
Bornstein SR,
Ehrhart-Bornstein M,
Scherbaum WA,
and
Holst JJ.
Angiotensin II regulates both adrenocortical and adrenomedullary function in isolated perfused pig adrenals.
Peptides
17:
287-292,
1996[ISI][Medline].
5.
Brown, DL,
and
Guyenet PG.
Cardiovascular neurons of brain stem with projections to spinal cord.
Am J Physiol Regulatory Integrative Comp Physiol
247:
R1009-R1016,
1984
6.
Brown, DL,
and
Guyenet PG.
Electrophysiological study of cardiovascular neurons in the rostral ventrolateral medulla in rats.
Circ Res
56:
359-369,
1985
7.
Carlsson, S,
Skarphedinsson JO,
Delle M,
Hoffman P,
and
Thoren P.
Differential responses in post- and pre-ganglionic adrenal sympathetic nerve activity and renal sympathetic nerve activity after injection of 2-deoxy-D-glucose and insulin in rats.
Acta Physiol Scand
145:
169-175,
1992[ISI][Medline].
8.
Carlsson, S,
Skarphedinsson JO,
Delle M,
Hoffman P,
and
Thoren P.
Reflex changes in post- and preganglionic sympathetic adrenal nerve activity and postganglionic sympathetic renal nerve activity upon arterial baroreceptor activation and during severe haemorrhage in the rat.
Acta Physiol Scand
144:
317-323,
1992[ISI][Medline].
9.
Carlsson, S,
Skarphedinsson JO,
Jennische E,
Delle M,
and
Thoren P.
Neurophysiological evidence for and characterization of the post-ganglionic innervation of the adrenal gland in the rat.
Acta Physiol Scand
140:
491-499,
1990[ISI][Medline].
10.
Claassen, DE,
Morgan DA,
Hirai T,
and
Kenney MJ.
Nonuniform sympathetic nerve responses after sustained elevation in arterial pressure.
Am J Physiol Regulatory Integrative Comp Physiol
271:
R1264-R1269,
1996
11.
Cohen, WR,
Piasecki GJ,
Cohn HE,
Susa JB,
and
Jackson BT.
Sympathoadrenal responses during hypoglycemia, hyperinsulinemia, and hypoxemia in the ovine fetus.
Am J Physiol Endocrinol Metab
261:
E95-E102,
1991
12.
Corwin, EJ,
Seaton JF,
Hamaji M,
and
Harrison TS.
Central role for angiotensin in control of adrenal catecholamine secretion.
Am J Physiol Regulatory Integrative Comp Physiol
248:
R363-R370,
1985.
13.
Coupland, RE,
Pyper AS,
and
Hopwood D.
A method for differentiating between noradrenaline- and adrenaline-storing cells in the light and electron microscope.
Nature
201:
1240-1242,
1964.
14.
Dagerlind Pelto-Huikko, M,
Diez M,
and
Hókfelt T.
Adrenal medullary ganglion neurons project into the splanchnic nerve.
Neuroscience
69:
1019-1023,
1995[ISI][Medline].
15.
Dorsey, DA,
and
Schmidt RE.
Correlation of GAP-43 immunoreactivity with subpopulations of chromaffin cells in rat adrenal medulla.
Neurosci Lett
162:
29-33,
1993[ISI][Medline].
16.
Drake, K,
Gateva E,
Deutsch J,
and
Cohen WR.
Sex differences in the adrenal catecholamine response to hypoglycemia in rats.
Metabolism
47:
121-124,
1998[ISI][Medline].
17.
Edwards, AV,
and
Jones CT.
Autonomic control of adrenal function.
J Anat
183:
291-307,
1993.
18.
Edwards, SL,
Anderson CR,
Southwell BR,
and
McAllen RM.
Distinct preganglionic neurons innervate noradrenaline and adrenaline cells in the cat adrenal medulla.
Neuroscience
70:
825-832,
1996[ISI][Medline].
19.
Fater, DC,
Sundet WD,
Schultz HD,
and
Goetz KL.
Arterial baroreceptors have minimal physiological effects on adrenal medullary secretion.
Am J Physiol Heart Circ Physiol
244:
H194-H200,
1983.
20.
Feuerstein, G,
Boonyaviroj P,
Gutman Y,
Khosla MC,
and
Bumpus FM.
Adrenal catecholamine response to haemorrhage abolished by an angiotensin antagonist.
Eur J Pharmacol
41:
85-86,
1977[ISI][Medline].
21.
Folkow, B,
and
von Euler US.
Selective activation of noradrenaline and adrenaline producing cells in the cat's adrenal gland by hypothalamic stimulation.
Circ Res
2:
191-195,
1954
22.
Gagner, JP,
Gauthier S,
and
Sourkes TL.
Descending spinal pathways mediating the responses of adrenal tyrosine hydroxylase and catecholamines to insulin and 2-deoxyglucose.
Brain Res
325:
187-197,
1985[ISI][Medline].
23.
Goldstein, M,
Fuxe K,
Hokfelt T,
and
Joh TH.
Immunohistochemical studies on phenylethanolamine-N-methyltransferase, dopa-decarboxylase and dopaminehydroxylase.
Experientia
27:
951-952,
1971[ISI][Medline].
24.
Grynszpan-Winograd, O.
Adrenaline and noradrenaline cells in the adrenal medulla of the hamster: a morphological study of their innervation.
J Neurocytol
3:
341-361,
1974[ISI][Medline].
25.
Hillarp, NA,
and
Hokfelt B.
Evidence of adrenaline and noradrenaline in separate adrenal medullary cells.
Acta Physiol Scand
25:
1-134,
1953.
26.
Ito, K,
Sato A,
Shimamura K,
and
Swenson RS.
Reflex changes in sympatho-adrenal medullary functions in response to baroreceptor stimulation in anesthetized rats.
J Auton Nerv Syst
10:
295-303,
1984[ISI][Medline].
27.
Jensen, I,
Pilowsky P,
Llewellyn-Smith I,
Minson J,
and
Chalmers J.
Sympathetic preganglionic neurons projecting to the adrenal medulla and aorticorenal ganglion in the rabbit.
Brain Res
586:
125-129,
1992[ISI][Medline].
28.
Kesse, WK,
Parker TL,
and
Coupland RE.
The innervation of the adrenal gland. I. The source of pre- and postganglionic nerve fibres to the rat adrenal gland.
J Anat
157:
33-41,
1988[ISI][Medline].
29.
Klevans, LR,
and
Gebber GL.
Comparison of differential secretion of adrenal catecholamines by splanchnic nerve stimulation and cholinergic agents.
J Pharmacol Exp Ther
172:
69-76,
1970
30.
Kurosawa, M,
Sato A,
Sato Y,
and
Suzuki H.
Undiminished reflex responses of adrenal sympathetic nerve activity to stimulation of baroreceptors and cutaneous mechanoreceptors in aged rats.
Neurosci Lett
77:
193-198,
1987[ISI][Medline].
31.
Kuzmin, AI,
Pogorelov VM,
Zaretsky DV,
Medvedev OS,
and
Chazov EI.
Comparison of the effects of 2-deoxyglucose and immobilization on secretion and synthesis rate of catecholamines in the adrenal gland: A microdialysis study in conscious rats.
Acta Physiol Scand
155:
147-155,
1995[ISI][Medline].
32.
Lipski, J,
Kanjhan R,
Kruszewska B,
and
Rong W.
Properties of presympathetic neurones in the rostral ventrolateral medulla in the rat: an intracellular study "in vivo."
J Physiol (Lond)
490:
729-744,
1996[ISI][Medline].
33.
MacLean, MR,
and
Ungar A.
Effects of the renin-angiotensin system on the reflex response of the adrenal medulla to hypotension in the dog.
J Physiol (Lond)
373:
343-352,
1986
34.
Medvedev, OS,
Selivanov VN,
and
Kuzmin AI.
Selective activation of adrenaline secretion by the rat adrenal in neuroglycopenia detected via microdialysis.
Fiziol Zh
76:
1172-1178,
1996.
35.
Morrison, SF.
Raphe pallidus excites a unique class of sympathetic preganglionic neurons.
Am J Physiol Regulatory Integrative Comp Physiol
265:
R82-R89,
1993
36.
Morrison, SF,
Milner TA,
and
Reis DJ.
Reticulospinal vasomotor neurons of the rat rostral ventrolateral medulla: relationship to sympathetic nerve activity and the C1 adrenergic cell group.
J Neurosci
8:
1286-1301,
1988[Abstract].
37.
Morrison, SF,
and
Reis DJ.
Responses of sympathetic preganglionic neurons to rostral ventrolateral medullary stimulation.
Am J Physiol Regulatory Integrative Comp Physiol
261:
R1247-R1256,
1991
38.
Nijima, A.
Baroreceptor effects on renal and adrenal nerve activity.
Am J Physiol
230:
1733-1736,
1976.
39.
Paxinos, G,
and
Watson C.
The Rat Brain in Stereotaxic Coordinates. Sydney, Australia: Academic, 1986.
40.
Pyner, S,
and
Coote JH.
Evidence that sympathetic preganglionic neurones are arranged in target-specific columns in the thoracic spinal cord of the rat.
J Comp Neurol
342:
15-22,
1994[ISI][Medline].
41.
Rappaport, EB,
Young JB,
and
Landsberg L.
Effects of 2-deoxy-D-glucose on the cardiac sympathetic nerves and the adrenal medulla in the rat: further evidence for a dissociation of sympathetic nervous system and adrenal medullary responses.
Endocrinology
110:
650-656,
1982[Abstract].
42.
Robinson, RL,
Culberson JL,
and
Carmichael SW.
Influence of hypothalamic stimulation on the secretion of adrenal medullary catecholamines.
J Auton Nerv Syst
8:
89-96,
1983[ISI][Medline].
43.
Scheurink, A,
and
Ritter S.
Sympathoadrenal responses to glucoprivation and lipoprivation in rats.
J Neurochem
50:
1302-1308,
1993[ISI][Medline].
44.
Schramm, LP,
Adair JR,
Stribling JM,
and
Gray LP.
Preganglionic innervation of the adrenal gland of the rat: a study using horseradish peroxidase.
Exp Neurol
49:
540-553,
1975[ISI][Medline].
45.
Schreihofer, AM,
and
Guyenet PG.
Identification of C1 presympathetic neurons in rat rostral ventrolateral medulla by juxtacellular labeling in vivo.
J Comp Neurol
387:
524-536,
1997[ISI][Medline].
46.
Strack, AM,
Sawyer WB,
Marubio LM,
and
Loewy AD.
Spinal origin of sympathetic preganglionic neurons in the rat.
Brain Res
455:
187-191,
1988[ISI][Medline].
47.
Strack, AM,
Sawyer WB,
Platt KB,
and
Loewy AD.
CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus.
Brain Res
491:
274-296,
1989[ISI][Medline].
48.
Sun, CL,
Thoa NB,
and
Kopin IJ.
Comparison of the effects of 2-deoxyglucose and immobilization on plasma levels of catecholamines and corticosterone in awake rats.
J Endocrinol
105:
305-311,
1979.
49.
Tochihara, M.
Reflex control of cardiac sympathetic nerve activity in anesthetized rats.
Hokkaido Igaku Zasshi
71:
247-258,
1996[Medline].
50.
Tomlinson, A,
and
Coupland RE.
The innervation of the adrenal gland. IV. Innervation of the rat adrenal medulla from birth to old age A descriptive and quantitative morphometric and biochemical study of the innervation of chromaffin cells and adrenal medullary neurons in Wistar rats.
J Anat
169:
209-236,
1990[ISI][Medline].
51.
Victor, RG,
Thoren P,
Morgan DA,
and
Mark AL.
Differential control of adrenal and renal sympathetic nerve activity during hemorrhagic hypotension in rats.
Circ Res
64:
686-694,
1989
52.
Vollmer, RR.
Selective neural regulation of epinephrine and norepinephrine cells in the adrenal medulla
cardiovascular implications.
Clin Exp Hypertens
18:
731-751,
1996.
53.
Vollmer, RR,
Balcita JJ,
Sved AF,
and
Edwards DJ.
Adrenal epinephrine and norepinephrine release to hypoglycemia measured by microdialysis in conscious rats.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1758-R1763,
1997
54.
Vollmer, RR,
Baruchin A,
Kolibal-Pegher SS,
Corey SP,
Stricker EM,
and
Kaplan BB.
Selective activation of norepinephrine- and epinephrine-secreting chromaffin cells in rat adrenal medulla.
Am J Physiol Regulatory Integrative Comp Physiol
263:
R716-R721,
1992
55.
Vollmer, RR,
Corey SP,
Meyers SA,
Stricker EM,
and
Fluharty SJ.
Angiotensin augments epinephrine release in pithed rats fed a low-sodium diet.
Am J Physiol Regulatory Integrative Comp Physiol
258:
R187-R192,
1990
56.
Wesselingh, SL,
Li YW,
and
Blessing WW.
PNMT-containing neurons in the rostral medulla oblongata (C1, C3 groups) are transneuronally labelled after injection of herpes simplex virus type 1 into the adrenal gland.
Neurosci Lett
106:
99-104,
1989[ISI][Medline].
57.
Zagon, A,
and
Smith AD.
Monosynaptic projections from the rostral ventrolateral medulla oblongata to identified sympathetic preganglionic neurons.
Neuroscience
54:
729-743,
1993[ISI][Medline].
This article has been cited by other articles:
![]() |
M. M. J. Farnham, Q. Li, A. K. Goodchild, and P. M. Pilowsky PACAP is expressed in sympathoexcitatory bulbospinal C1 neurons of the brain stem and increases sympathetic nerve activity in vivo Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1304 - R1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Matveyenko, M. Bohland, M. Saberi, and C. M. Donovan Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E857 - E864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Madden, S. D. Stocker, and A. F. Sved Attenuation of homeostatic responses to hypotension and glucoprivation after destruction of catecholaminergic rostral ventrolateral medulla neurons Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R751 - R759. [Abstract] [Full Text] [PDF] |
||||